India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

By: IPP Bureau

Last updated : June 16, 2026 8:41 am



From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape


India’s science, technology, and innovation ecosystem has witnessed unprecedented growth over the past twelve years, according to Union Minister of State (Independent Charge) for Science & Technology, Dr. Jitendra Singh.

Addressing a press conference titled “12 Years of Transformative Growth in Science, Technology and Innovation” at the CSIR Headquarters in New Delhi, Dr. Singh highlighted the remarkable strides made across biotechnology, healthcare, space, weather sciences, clean energy, and advanced manufacturing under the leadership of Prime Minister Narendra Modi.

One of the most significant achievements has been the rapid expansion of India’s bioeconomy, which has grown nearly twenty-fold—from approximately USD 10 billion in 2014 to more than USD 190 billion today, claimed the Minister. 

Dr. Singh outlined that the government has set an ambitious target of expanding the bioeconomy to USD 300 billion by 2030, driven by innovations in biotechnology, genomics, diagnostics, biopharmaceuticals, and precision medicine.

Dr. Singh noted that India has emerged as a global biotechnology hub through indigenous research and innovation, supported by progressive initiatives such as the BioE3 Policy. 

The minister emphasized that scientific research is increasingly translating into real-world impact, with technologies developed by institutions such as CSIR being adopted across sectors ranging from healthcare and agriculture to infrastructure and energy.

Programmes such as the Aroma Mission have helped create new livelihood opportunities for farmers, while innovations like steel slag road technology are promoting sustainable infrastructure development through the productive use of industrial waste.

India’s healthcare and biotechnology ecosystem has also benefited from strengthened innovation networks, startup support programmes, and research initiatives led by the Department of Biotechnology and the Department of Science and Technology. Key national programmes such as the Anusandhan National Research Foundation (ANRF), National Quantum Mission, Research Development and Innovation Fund, National Supercomputing Mission, and National Geospatial Policy are helping build a robust foundation for future scientific growth.

Dr. N. Kalaiselvi, Director General of CSIR, highlighted progress under Mission Mausam and the Deep Ocean Mission, including the development of indigenous deep-sea technologies such as Matsya 6000 and Varaha. 

Dr. Rajesh Gokhale, Secretary of the Department of Biotechnology, outlined achievements in biotechnology, genomics, startup development, and healthcare innovation, underscoring India's growing role in the global life sciences ecosystem.

 

bioeconomy biotech Dr Jitendra Singh BioE3 CAR-T biopharmaceuticals

First Published : June 16, 2026 12:00 am